GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 2511.00 25.15 (1.01%) | NSE 2516.20 32.20 (1.30%) | Trade | Add

BSE Live

Feb 09, 16:01

2511.00 25.15 (1.01%)

Volume

AVERAGE VOLUME

5-Day

3,213

10-Day

2,660

30-Day

3,024

6,012

Prev. Close

2485.85
Open Price

2409.25

Bid Price (Qty.)
2511.00 (190)
Offer Price (Qty.)
2525.00 (5)

NSE Live

Feb 09, 15:59

2516.20 32.20 (1.30%)

Volume

AVERAGE VOLUME

5-Day

71,360

10-Day

71,501

30-Day

83,396

104,890

Prev. Close

2484.00
Open Price

2489.00

Bid Price (Qty.)
2516.20 (787)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Dec 09	Dec 08	Dec 07	Dec 06	Dec 05
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	84.70	84.70	84.70	84.70	84.70
Total Share Capital	84.70	84.70	84.70	84.70	84.70
Reserves and Surplus	1,674.45	1,456.39	1,276.21	1,110.01	863.90
Total Reserves and Surplus	1,674.45	1,456.39	1,276.21	1,110.01	863.90
Total Shareholders Funds	1,759.15	1,541.09	1,360.92	1,194.71	948.61
NON-CURRENT LIABILITIES
Long Term Borrowings	5.42	5.65	5.74	5.52	4.83
Deferred Tax Liabilities [Net]	7.59	9.11	9.82	10.58	11.41
Other Long Term Liabilities	0.00	0.00	0.00	0.00	0.00
Long Term Provisions	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	13.01	14.76	15.56	16.09	16.24
CURRENT LIABILITIES
Short Term Borrowings	0.00	0.00	0.02	0.02	0.02
Trade Payables	291.38	251.66	226.30	230.63	237.46
Other Current Liabilities	25.29	19.94	18.48	17.08	20.10
Short Term Provisions	382.96	454.51	392.55	318.15	290.55
Total Current Liabilities	699.62	726.11	637.35	565.89	548.13
Total Capital And Liabilities	2,471.78	2,281.96	2,013.82	1,776.69	1,512.98
ASSETS
NON-CURRENT ASSETS
Tangible Assets	92.81	90.40	87.47	85.80	64.39
Intangible Assets	0.00	0.00	0.00	0.00	17.18
Capital Work-In-Progress	21.36	9.95	5.43	8.66	15.37
Other Assets	0.00	0.00	0.00	0.00	0.00
Fixed Assets	114.17	100.35	92.90	94.46	96.94
Non-Current Investments	190.91	751.87	1,333.32	1,139.41	913.06
Deferred Tax Assets [Net]	52.28	38.70	29.96	35.19	41.18
Long Term Loans And Advances	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	357.36	890.93	1,456.18	1,269.06	1,051.18
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	0.00
Inventories	253.02	228.38	205.96	240.95	218.13
Trade Receivables	53.73	57.94	37.77	60.45	67.39
Cash And Cash Equivalents	1,672.60	906.54	154.99	35.03	47.53
Short Term Loans And Advances	132.05	195.14	155.89	168.19	123.85
OtherCurrentAssets	3.02	3.02	3.02	3.02	4.91
Total Current Assets	2,114.42	1,391.03	557.64	507.64	461.80
Total Assets	2,471.78	2,281.96	2,013.82	1,776.69	1,512.98
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	208.47	258.47	208.40	264.97	142.49
CIF VALUE OF IMPORTS
Raw Materials	174.10	158.78	127.57	131.44	112.22
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	2.23	5.27	2.28	2.10	2.79
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	3.85	2.68	3.96	2.69	1.85
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	171.67	154.50	133.04	120.17	103.00
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	71.50	59.27	40.32	30.18	27.32
Other Earnings	50.70	37.01	43.41	29.14	18.70
BONUS DETAILS
Bonus Equity Share Capital	40.69	40.69	40.69	40.69	40.69
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	146.32	306.84	504.07	364.91	525.81
Non-Current Investments Unquoted Book Value	47.67	444.67	1,081.70	907.67	486.59
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--